Based on these previous findings and indications, we propose that stage II colon cancer patients who have undergone a curative resection should be considered to be at a high risk for recurrence if they present with a pre-operative CEA level of twice the cut-off value and/or with a pre-operative bowel obstruction. The gene discussed is CEACAM5; the disease is colonic neoplasm.